Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Low-grade Upper Tract Urothelial Cancer Topic Center

Featured

Quiz
Identifying Chemotherapy Gel's Mechanism of Action
10/25/2022
Used for the treatment of patients with low-grade upper tract urothelial cancer, mitomycin works by inhibiting which of the following?
Used for the treatment of patients with low-grade upper tract urothelial cancer, mitomycin works by inhibiting which of the following?
Used for the treatment of...
10/25/2022
Pharmacy Learning Network
From Pharmacy Learning Network
News
Low Compliance With Most Diagnostic Recommendations for Upper Tract Urothelial Carcinoma
10/20/2022
Study authors evaluated clinical guideline adherence in the management of upper tract urothelial carcinoma.
Study authors evaluated clinical guideline adherence in the management of upper tract urothelial carcinoma.
Study authors evaluated clinical...
10/20/2022
Integrated Healthcare Executive
From Integrated Healthcare Executive
News
Reviewing Association of UTUC Pathological Characteristics With Daily Fluid Intake, Behavioral Habits
10/12/2022
Through a preoperative questionnaire survey, researchers analyzed the water drinking habits of patients with upper tract urothelial carcinoma and the connection to their pathological characteristics.
Through a preoperative questionnaire survey, researchers analyzed the water drinking habits of patients with upper tract urothelial carcinoma and the connection to their pathological characteristics.
Through a preoperative...
10/12/2022
Veterans Health Today
From Veterans Health Today
News
In Vitro Study Explores Potential Feasibility of Mitomycin-Coated Biodegradable Ureteral Stent
10/03/2022
“The addition of mitomycin C to the coating of silk fibroin stents could be an attractive approach for intracavitary instillation in the upper urinary tract,” concluded researchers, noting that more research is needed.
“The addition of mitomycin C to the coating of silk fibroin stents could be an attractive approach for intracavitary instillation in the upper urinary tract,” concluded researchers, noting that more research is needed.
“The addition of mitomycin C to...
10/03/2022
First Report Managed Care
From First Report Managed Care
News
Germline Mutation Screening in Patients With UTUC, Lynch Syndrome
09/20/2022
Upper tract urothelial carcinoma is the third most common cancer associated with Lynch syndrome; however, there is not an established guideline for identifying at patients with UTUC who are at risk of carrying germline mutations.
Upper tract urothelial carcinoma is the third most common cancer associated with Lynch syndrome; however, there is not an established guideline for identifying at patients with UTUC who are at risk of carrying germline mutations.
Upper tract urothelial carcinoma...
09/20/2022
Integrated Healthcare Executive
From Integrated Healthcare Executive
Literature Review
Bladder Cancers: What is Low-Grade Upper Tract Urothelial Carcinoma?
09/16/2022
This literature review explores key data related to the epidemiology, clinical presentation, and treatment considerations for patients with low-grade upper tract urothelial carcinoma.
This literature review explores key data related to the epidemiology, clinical presentation, and treatment considerations for patients with low-grade upper tract urothelial carcinoma.
This literature review explores...
09/16/2022
First Report Managed Care
From First Report Managed Care
Quiz
Prevalence of Low-Grade UTUC in Patients With Bladder Cancer
09/15/2022
Bladder cancer is the fourth most common type of cancer in US veterans. Among patients with upper tract urothelial carcinoma, how prevalent are low-grade cases?
Bladder cancer is the fourth most common type of cancer in US veterans. Among patients with upper tract urothelial carcinoma, how prevalent are low-grade cases?
Bladder cancer is the fourth...
09/15/2022
Veterans Health Today
From Veterans Health Today
Quiz
Reviewing Response Rates for Chemoablative UTUC Therapy Option
09/15/2022
Among patients with low-grade upper tract urothelial carcinoma enrolled in an open-label, single-arm, phase 3 trial, delivering chemoablative therapy to the upper tract via a reverse-thermal hydrogel led to a complete response rate of which...
Among patients with low-grade upper tract urothelial carcinoma enrolled in an open-label, single-arm, phase 3 trial, delivering chemoablative therapy to the upper tract via a reverse-thermal hydrogel led to a complete response rate of which...
Among patients with low-grade...
09/15/2022
Pharmacy Learning Network
From Pharmacy Learning Network
News
Avoiding Kidney Removal Among Patients With UTUC Through Chemoablation
08/19/2022
Data demonstrates finding alternatives to kidney removal among patients with low-grade upper tract urothelial cancer is key to improving patient quality of life.
Data demonstrates finding alternatives to kidney removal among patients with low-grade upper tract urothelial cancer is key to improving patient quality of life.
Data demonstrates finding...
08/19/2022
Integrated Healthcare Executive
From Integrated Healthcare Executive
News
Endoscopic Management Beneficial But Costly for Low-Grade Upper Tract Urothelial Carcinoma
08/18/2022
“Our findings support endoscopic management for low-grade upper tract urothelial carcinoma as a valid option from oncological aspects but highlight the associated costs,” wrote researchers.
“Our findings support endoscopic management for low-grade upper tract urothelial carcinoma as a valid option from oncological aspects but highlight the associated costs,” wrote researchers.
“Our findings support endoscopic...
08/18/2022
Veterans Health Today
From Veterans Health Today
Quiz
Weighing Options for Patients With Upper Tract Urothelial Carcinoma
08/17/2022
Patients with low-grade upper tract urothelial carcinoma always undergo radical nephroureterectomy to avoid further complications.
Patients with low-grade upper tract urothelial carcinoma always undergo radical nephroureterectomy to avoid further complications.
Patients with low-grade upper...
08/17/2022
Pharmacy Learning Network
From Pharmacy Learning Network

Newsfeed

News
Low Compliance With Most Diagnostic Recommendations for Upper Tract Urothelial Carcinoma
10/20/2022
Study authors evaluated clinical guideline adherence in the management of upper tract urothelial carcinoma.
Study authors evaluated clinical guideline adherence in the management of upper tract urothelial carcinoma.
Study authors evaluated clinical...
10/20/2022
Integrated Healthcare Executive
News
Reviewing Association of UTUC Pathological Characteristics With Daily Fluid Intake, Behavioral Habits
10/12/2022
Through a preoperative questionnaire survey, researchers analyzed the water drinking habits of patients with upper tract urothelial carcinoma and the connection to their pathological characteristics.
Through a preoperative questionnaire survey, researchers analyzed the water drinking habits of patients with upper tract urothelial carcinoma and the connection to their pathological characteristics.
Through a preoperative...
10/12/2022
Veterans Health Today
News
In Vitro Study Explores Potential Feasibility of Mitomycin-Coated Biodegradable Ureteral Stent
10/03/2022
“The addition of mitomycin C to the coating of silk fibroin stents could be an attractive approach for intracavitary instillation in the upper urinary tract,” concluded researchers, noting that more research is needed.
“The addition of mitomycin C to the coating of silk fibroin stents could be an attractive approach for intracavitary instillation in the upper urinary tract,” concluded researchers, noting that more research is needed.
“The addition of mitomycin C to...
10/03/2022
First Report Managed Care
News
Germline Mutation Screening in Patients With UTUC, Lynch Syndrome
09/20/2022
Upper tract urothelial carcinoma is the third most common cancer associated with Lynch syndrome; however, there is not an established guideline for identifying at patients with UTUC who are at risk of carrying germline mutations.
Upper tract urothelial carcinoma is the third most common cancer associated with Lynch syndrome; however, there is not an established guideline for identifying at patients with UTUC who are at risk of carrying germline mutations.
Upper tract urothelial carcinoma...
09/20/2022
Integrated Healthcare Executive
News
Avoiding Kidney Removal Among Patients With UTUC Through Chemoablation
08/19/2022
Data demonstrates finding alternatives to kidney removal among patients with low-grade upper tract urothelial cancer is key to improving patient quality of life.
Data demonstrates finding alternatives to kidney removal among patients with low-grade upper tract urothelial cancer is key to improving patient quality of life.
Data demonstrates finding...
08/19/2022
Integrated Healthcare Executive
News
Endoscopic Management Beneficial But Costly for Low-Grade Upper Tract Urothelial Carcinoma
08/18/2022
“Our findings support endoscopic management for low-grade upper tract urothelial carcinoma as a valid option from oncological aspects but highlight the associated costs,” wrote researchers.
“Our findings support endoscopic management for low-grade upper tract urothelial carcinoma as a valid option from oncological aspects but highlight the associated costs,” wrote researchers.
“Our findings support endoscopic...
08/18/2022
Veterans Health Today
News
Addressing Unmet Needs for Patients With Low-grade Upper Tract Urothelial Carcinoma
08/17/2022
Despite being one of the most common types of bladder cancer, urothelial carcinoma presents several challenges to patients due to the diseases’ tendency to expand and spread cells to other parts of the urinary tract, including the kidney.
Despite being one of the most common types of bladder cancer, urothelial carcinoma presents several challenges to patients due to the diseases’ tendency to expand and spread cells to other parts of the urinary tract, including the kidney.
Despite being one of the most...
08/17/2022
First Report Managed Care
News
Urothelial Carcinoma Molecular Subtype Could Guide Use of Neoadjuvant Chemotherapy
08/09/2022
Cancer subtype was associated with different rates of complete pathological response in patients with urothelial carcinoma.
Cancer subtype was associated with different rates of complete pathological response in patients with urothelial carcinoma.
Cancer subtype was associated...
08/09/2022
First Report Managed Care
News
FDA Approves Sacituzumab Govitecan for Advanced Urothelial Cancer
04/13/2021
The FDA has granted accelerated approval to sacituzumab govitecan for the treatment of certain adults with locally advanced or metastatic urothelial cancer.
The FDA has granted accelerated approval to sacituzumab govitecan for the treatment of certain adults with locally advanced or metastatic urothelial cancer.
The FDA has granted accelerated...
04/13/2021
Oncology
News
FDA Approves Avelumab for Advanced or Metastatic Urothelial Carcinoma
07/01/2020
The FDA approved avelumab for the first-line maintenance treatment of patients with locally advanced metastatic or urothelial carcinoma who have not progressed on first-line platinum-containing chemotherapy.
The FDA approved avelumab for the first-line maintenance treatment of patients with locally advanced metastatic or urothelial carcinoma who have not progressed on first-line platinum-containing chemotherapy.
The FDA approved avelumab for...
07/01/2020
Oncology
News
Increased Scrutiny of Prior Authorization: Are Payers Fully to Blame, and Can AI Improve the Process?
04/05/2024
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior...
04/05/2024
First Report Managed Care
News
PhRMA Maps Provide State-by-State Look at 340B Drug Program
04/05/2024
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made...
04/05/2024
First Report Managed Care
News
FTC and HHS Launch Joint Inquiry into Generic Drug Shortages: Seeking Public Input on GPOs and Wholesalers
02/16/2024
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on...
02/16/2024
First Report Managed Care
News
Medicare Drug Price Negotiations and Anticipated Ripple Effects
02/15/2024
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation...
02/15/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
First Gene Therapy for Severe Hemophilia A Is Approved
06/29/2023
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a...
06/29/2023
Population Health
News
Low Rate of Social Determinants of Health Z Codes in Adults With Hypertension
06/26/2023
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the...
06/26/2023
First Report Managed Care
News
CDC Data Shows Link Between High Costs and Prescription Nonadherence in Adults
06/21/2023
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence...
06/21/2023
First Report Managed Care
News
Blood Pressure Injections Recalled
05/26/2023
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network

Advertisement

Insights

Petros Grivas, MD, Fred Hutchinson Cancer Center
Podcasts
Sacituzumab Govitecan Plus Pembrolizumab Yields Encouraging Response Rates in Metastatic Urothelial Cancer
06/22/2022
Petros Grivas, MD, shares results from the phase 2 TROPHY-U-01 trial evaluating the sacituzumab govitecan in combination with pembrolizumab for patients with metastatic urothelial cancer who progressed after platinum-based regimens.
Petros Grivas, MD, shares results from the phase 2 TROPHY-U-01 trial evaluating the sacituzumab govitecan in combination with pembrolizumab for patients with metastatic urothelial cancer who progressed after platinum-based regimens.
Petros Grivas, MD, shares...
06/22/2022
Oncology
Robert Jones, MD
Podcasts
Maintenance Therapy With Cabozantinib Shows No Significant Benefit vs Placebo for Metastatic Urothelial Carcinoma
06/21/2022
Robert Jones, MD, shares results and insights from the phase 2 ATLANTIS trial, evaluating maintenance cabozantinib following platinum-based chemotherapy for patients with metastatic urothelial carcinoma.
Robert Jones, MD, shares results and insights from the phase 2 ATLANTIS trial, evaluating maintenance cabozantinib following platinum-based chemotherapy for patients with metastatic urothelial carcinoma.
Robert Jones, MD, shares results...
06/21/2022
Oncology
First-Line Treatment Approaches for Metastatic Urothelial Cancer in the US
Videos
First-Line Treatment Approaches for Metastatic Urothelial Cancer in the US
05/04/2021
Petros Grivas, MD, PhD, discusses results from a study exploring decision-making processes regarding first-line treatment choices, testing practices and treatment eligibility determinants for patients with metastatic urothelial cancer.
Petros Grivas, MD, PhD, discusses results from a study exploring decision-making processes regarding first-line treatment choices, testing practices and treatment eligibility determinants for patients with metastatic urothelial cancer.
Petros Grivas, MD, PhD,...
05/04/2021
Journal of Clinical Pathways
Real-World Survival Trends in Muscle-Invasive Bladder Cancer and Urothelial Carcinoma
Videos
Real-World Survival Trends in Muscle-Invasive Bladder Cancer and Urothelial Carcinoma
03/12/2021
Nimira Alimohamed, MD, discusses results from a real-world analysis of outcomes over time in patients with muscle-invasive bladder cancer and patients with metastatic urothelial carcinoma.
Nimira Alimohamed, MD, discusses results from a real-world analysis of outcomes over time in patients with muscle-invasive bladder cancer and patients with metastatic urothelial carcinoma.
Nimira Alimohamed, MD, discusses...
03/12/2021
Journal of Clinical Pathways
Study Finds No Correlation Between Antibiotic Use and OS in Metastatic Urothelial Carcinoma
Videos
Study Finds No Correlation Between Antibiotic Use and OS in Metastatic Urothelial Carcinoma
02/19/2021
Shilpa Gupta, MD, discusses the effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitors on overall survival among patients with metastatic urothelial carcinoma in real-world practice.
Shilpa Gupta, MD, discusses the effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitors on overall survival among patients with metastatic urothelial carcinoma in real-world practice.
Shilpa Gupta, MD, discusses the...
02/19/2021
Journal of Clinical Pathways
Commentary
Making Contract Management Work in a Value-Based Care Environment
06/12/2024
Lynn Carroll, Chief Operating Officer, HSBlox
David Wolf, Vice President of Product Management, MedeAnalytics
Value-based care (VBC) models aim improve clinical outcomes and reduce health care costs by proactively focusing on patient wellness. To make this preventive approach to individual and population care work, patients, providers, payers, and...
Value-based care (VBC) models aim improve clinical outcomes and reduce health care costs by proactively focusing on patient wellness. To make this preventive approach to individual and population care work, patients, providers, payers, and...
Value-based care (VBC) models...
06/12/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
James Wallace Headshot
Commentary
The Key to Improving Medication Adherence: The “Right” Medication for Each Patient
03/08/2024

James Wallace, CEO of DecisionRx

James Wallace, CEO of DecisionRx ...
Medication adherence poses a significant challenge in health care, with far-reaching consequences for patients and the health care system. It is a complex issue influenced by various factors, including undesirable side effects, lack of...
Medication adherence poses a significant challenge in health care, with far-reaching consequences for patients and the health care system. It is a complex issue influenced by various factors, including undesirable side effects, lack of...
Medication adherence poses a...
03/08/2024
First Report Managed Care
KOL Headshots
Commentary
2024 Predictions: Key Trends Identified by Business Leaders and Health Care Experts in Value-Based Care
01/23/2024
In this exclusive commentary for First Report Managed Care, health experts and business leaders share insights into predictions for the 2024 value-based care landscape. Insights highlight trends in behavioral health, AI integration,...
In this exclusive commentary for First Report Managed Care, health experts and business leaders share insights into predictions for the 2024 value-based care landscape. Insights highlight trends in behavioral health, AI integration,...
In this exclusive commentary for...
01/23/2024
First Report Managed Care
Commentary
Can FDA's Florida Drug Import Program Cut Costs and Boost Medication Access?
01/11/2024
The FDA granted Florida permission to import drugs from Canada under section 804 of the Federal Food, Drug, and Cosmetic Act. But how will it affect the current prescription drug landscape across the US?
The FDA granted Florida permission to import drugs from Canada under section 804 of the Federal Food, Drug, and Cosmetic Act. But how will it affect the current prescription drug landscape across the US?
The FDA granted Florida...
01/11/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Court Allows Patients to Sue Pharmacy Over Data Breach
01/11/2024
A United States Appeals Court overturned a lower court’s decision to dismiss a case and is allowing patients of a pharmacy who were affected by a data breach to continue their lawsuit against the pharmacy.
A United States Appeals Court overturned a lower court’s decision to dismiss a case and is allowing patients of a pharmacy who were affected by a data breach to continue their lawsuit against the pharmacy.
A United States Appeals Court...
01/11/2024
Pharmacy Learning Network
9 KOL leaders in health care headshots
Commentary
2024 Predictions From Health Executives: Advancements in Genetic Testing, AI in Health Care, and Cybersecurity Challenges
01/10/2024
After a year of pharmacogenetic testing coverage, automation enhancements, and challenges related to cybersecurity, 9 health care executives across organizations predict where the industry is headed in 2024.
After a year of pharmacogenetic testing coverage, automation enhancements, and challenges related to cybersecurity, 9 health care executives across organizations predict where the industry is headed in 2024.
After a year of pharmacogenetic...
01/10/2024
Integrated Healthcare Executive
Podcasts
A Payer's Perspective on Value-Based Care and Treatment Costs for Rheumatic Conditions
11/06/2023
Dr Steven Peskin, general internal medicine specialist and CEO of SRP Advisors, joins us today to discuss value-based care and treatment costs for patients with rheumatic conditions.
Dr Steven Peskin, general internal medicine specialist and CEO of SRP Advisors, joins us today to discuss value-based care and treatment costs for patients with rheumatic conditions.
Dr Steven Peskin, general...
11/06/2023
First Report Managed Care
Headshot of Derek Streat on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Problems and Innovations in Streamlining Virtual Care Services
09/29/2023
Derek Streat, Co-Founder, CEO, and Chairman of DexCare, joins us today to learn about how DexCare technology’s Get Care Now program in partnership with UR Medicine is finding ways to virtually connect patients with providers faster.
Derek Streat, Co-Founder, CEO, and Chairman of DexCare, joins us today to learn about how DexCare technology’s Get Care Now program in partnership with UR Medicine is finding ways to virtually connect patients with providers faster.
Derek Streat, Co-Founder, CEO,...
09/29/2023
Integrated Healthcare Executive

Advertisement

Advertisement

Advertisement

Recent Stories

Quiz
Identifying Chemotherapy Gel's Mechanism of Action
10/25/2022
Used for the treatment of patients with low-grade upper tract urothelial cancer, mitomycin works by inhibiting which of the following?
Used for the treatment of patients with low-grade upper tract urothelial cancer, mitomycin works by inhibiting which of the following?
Used for the treatment of...
10/25/2022
Pharmacy Learning Network
News
Low Compliance With Most Diagnostic Recommendations for Upper Tract Urothelial Carcinoma
10/20/2022
Study authors evaluated clinical guideline adherence in the management of upper tract urothelial carcinoma.
Study authors evaluated clinical guideline adherence in the management of upper tract urothelial carcinoma.
Study authors evaluated clinical...
10/20/2022
Integrated Healthcare Executive
News
Reviewing Association of UTUC Pathological Characteristics With Daily Fluid Intake, Behavioral Habits
10/12/2022
Through a preoperative questionnaire survey, researchers analyzed the water drinking habits of patients with upper tract urothelial carcinoma and the connection to their pathological characteristics.
Through a preoperative questionnaire survey, researchers analyzed the water drinking habits of patients with upper tract urothelial carcinoma and the connection to their pathological characteristics.
Through a preoperative...
10/12/2022
Veterans Health Today
News
In Vitro Study Explores Potential Feasibility of Mitomycin-Coated Biodegradable Ureteral Stent
10/03/2022
“The addition of mitomycin C to the coating of silk fibroin stents could be an attractive approach for intracavitary instillation in the upper urinary tract,” concluded researchers, noting that more research is needed.
“The addition of mitomycin C to the coating of silk fibroin stents could be an attractive approach for intracavitary instillation in the upper urinary tract,” concluded researchers, noting that more research is needed.
“The addition of mitomycin C to...
10/03/2022
First Report Managed Care
News
Germline Mutation Screening in Patients With UTUC, Lynch Syndrome
09/20/2022
Upper tract urothelial carcinoma is the third most common cancer associated with Lynch syndrome; however, there is not an established guideline for identifying at patients with UTUC who are at risk of carrying germline mutations.
Upper tract urothelial carcinoma is the third most common cancer associated with Lynch syndrome; however, there is not an established guideline for identifying at patients with UTUC who are at risk of carrying germline mutations.
Upper tract urothelial carcinoma...
09/20/2022
Integrated Healthcare Executive

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement